Impact of Cardiac Complications on Outcomes of Patients After Subarachnoid Hemorrhage

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04177329

Enrollment

Registered

2019-11-26

Start date

2019-12-01

Completion date

2020-12-01

Last updated

2019-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subarachnoid Hemorrhage

Brief summary

Patients with subarachnoid haemorrhage frequently develop cardiac complications affecting their outcome

Interventions

None listed

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* Patients diagnosed as spontaneous subarachnoid hemorrhage. * SSAH patients aged (18-70 years) of both sexes

Exclusion criteria

* History or current evidence of any CNS disease other than SAH which may cause cardiac complications. * History or current evidence of medical illness as endocrinal and metabolic disorders which may cause cardiac complications

Design outcomes

Primary

Measure	Time frame	Description
Electrocadriogram	1 miute	to measure heart rate (beats/minute) in subarachnoid hemorrhage patients
Echocardiogarphy	30 minute	to measure ejection fraction (%) in subarachnoid hemorrhage patients

Secondary

Measure	Time frame	Description
serum treponin level	30 minute	to measure serum treponin(ng/ml)in subarachnoid hemorrhage patients

Outcome results